Clinical significance of MicoRNA-155 expression in human breast cancer

Journal of Surgical Oncology

Volumn 106, Issue 3, 2012, Pages 260-266

  Chen, Jian ^a,b   Wang, Bing Chan ^c   Tang, Jin Hai ^a,d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d Jiangsu Province Tumor Hospital   (China)

Author keywords

breast cancer; disease free survival; microRNA 155; overall survival; prognosis; radiosensitivity

Indexed keywords

MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEIC ACID PROBE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; BREAST; BREAST TUMOR; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84864651097     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22153     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Long N, Moore MA, Chen W, et al.: Cancer epidemiology and control in north-East Asia-past, present and future. Asian Pac J Cancer Prev 2010; 11: 107-148.
3. Bartel DP,: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
4. Baek D, Villen J, Shin C, et al.: The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
5. Mendell JT,: MicroRNAs: Critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005; 4: 1179-1184.
6. Alvarez-Garcia I, Miska EA,: MicroRNA functions in animal development and human disease. Development 2005; 132: 4653-4662.
7. Rothé F, Ignatiadis M, Chaboteaux C, et al.: Global MicroRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 2011; 6: e20980.
8. Wu ZS, Wu Q, Wang CQ, et al.: miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011; 117: 2842-2852.
9. Kastl L, Brown I, Schofield AC,: miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat 2011 Mar 12. [Epub ahead of print].
10. Liang Z, Wu H, Xia J, et al.: Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2010; 79: 817-824.
11. Jiang S, Zhang HW, Lu MH, et al.: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70: 3119-3127.
12. Kong W, Yang H, He L,: et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28: 6773-6784.
13. Kong W, He L, Coppola M, et al.: MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010; 285: 17869-17879.
14. Soifer HS, Rossi JJ, Saetrom P,: MicroRNAs in disease and potential therapeutic applications. Mol Ther 2007; 15: 2070-2079.
15. Götte M,: MicroRNAs in breast cancer pathogenesis. Minerva Ginecol 2010; 62: 559-571.
16. Di Leva G, Croce CM,: Roles of small RNAs in tumor formation. Trends Mol Med 2010; 16: 257-267.
17. Dykxhoorn DM,: MicroRNAs and metastasis: Little RNAs go a long way. Cancer Res 2010; 70: 6401-6406.
18. Ma J, Dong C, Ji C,: MicroRNA and drug resistance. Cancer Gene Ther 2010; 17: 523-531.
19. Tam W, Ben-Yehuda D, Hayward WS,: bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997; 17: 1490-1502.
20. Kluiver J, Poppema S, de Jong D, et al.: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243-249.
21. Metzler M, Wilda M, Busch K, et al.: High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 167-169.
22. Ryu JK, Hong SM, Karikari CA, et al.: Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology 2010; 10: 66-73.
23. White NM, Bao TT, Grigull J, et al.: miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 2011; 186: 1077-1083.
24. Shibuya H, Iinuma H, Shimada R, et al.: Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010; 79: 313-320.
25. Du ZM, Hu LF, Wang HY, et al.: Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011; 6: e19137.
26. Zhang M, Zhang Q, Liu F,: et al. MicroRNA-155 may affect allograft survival by regulating the expression of suppressor of cytokine signaling 1. Med Hypotheses 2011; 77: 682-684.
27. Ollila DB, Stitzenberg KB,: Breast cancer sentinel node metastases: Histopathologic detection and clinical significance. Cancer Control 2001; 8: 407-414.
28. Keshtgar MR, Ell PJ,: Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002; 3: 105-110.
29. Koukourakis G,: Radiation therapy for early breast cancer. Clin Transl Oncol 2009; 11: 596-603.
30. Lee KM, Choi EJ, Kim IA,: microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 2011; 101: 171-176.
31. Kato M, Paranjape T, Müller RU, et al.: The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 2009; 28: 2419-2424.